SEARCH

SEARCH BY CITATION

References

  • 1
    Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst2000;92:150010.
  • 2
    De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev2008;17:54554.
  • 3
    Clifford GM, Gonçalves MAG, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS2006;20:233744.
  • 4
    Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, et al.Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis2001;184:68290.
  • 5
    Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N, et al.Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet2007;370:40713.
  • 6
    Kitchener H, Nelson L, Adams J, Mesher D, Sasieni P, Cubie H, et al.Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer2007;121:248491.
  • 7
    Denny L, Boa R, Williamson A, Allan B, Hardie D, Stan R, et al.Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol2008;111:13807.
  • 8
    Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, et al.Improved amplification of genital human papillomaviruses. J Clin Microbiol2000;38:35761.
  • 9
    Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, et al.Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology. J Acquir Immune Defic Syndr2009;50:16875.
  • 10
    Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, et al.High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol2010;115:11508.
  • 11
    Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, et al.HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer2000;85:20610.
  • 12
    McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA. Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol2010;116:5727.
  • 13
    Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, et al.Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst2003;95:106271.
  • 14
    Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer2003;89:1015.
  • 15
    Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al.A review of human carcinogens--Part B: biological agents. Lancet Oncol2009; 10:3212.
  • 16
    Haas S, Park T, Voigt E, Büttner R, Merkelbach-Bruse S. Detection of HPV 52, 58 and 87 in cervicovaginal intraepithelial lesions of HIV infected women. Int J Mol Med2005;16:8159.
  • 17
    Smits PHM, Bakker R, Jong E, Mulder JW, Meenhorst PL, Kleter B, et al.High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. J Clin Microbiol2005;43:59369.
  • 18
    Gagnon S, Hankins C, Money D, Pourreaux K, Franco E, Coutlée F. Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high risk or infected by HIV. J Acquir Immune Defic Syndr2007;44:615.
  • 19
    Anastos K, Hoover DR, Burk RD, Cajigas A, Shi Q, Singh DK, et al.Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS ONE2010;5:e13525.
  • 20
    Massad LS, Seaberg EC, Wright RL, Darragh T, Lee Y, Colie C, et al.Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up. Obstet Gynecol2008;111:138893.
  • 21
    Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, et al.The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS2001;15:215764.
  • 22
    Heard I, Tassie J, Kazatchkine MD, Orth G. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS2002;16:1799802.